Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs SYNCOM FORMULATIONS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA SYNCOM FORMULATIONS SANOFI INDIA/
SYNCOM FORMULATIONS
 
P/E (TTM) x 33.0 55.9 59.0% View Chart
P/BV x 14.8 6.4 229.9% View Chart
Dividend Yield % 2.7 0.0 -  

Financials

 SANOFI INDIA   SYNCOM FORMULATIONS
EQUITY SHARE DATA
    SANOFI INDIA
Dec-23
SYNCOM FORMULATIONS
Mar-24
SANOFI INDIA/
SYNCOM FORMULATIONS
5-Yr Chart
Click to enlarge
High Rs8,27819 44,383.9%   
Low Rs5,2406 90,344.8%   
Sales per share (Unadj.) Rs1,238.02.8 44,182.7%  
Earnings per share (Unadj.) Rs261.80.3 97,211.7%  
Cash flow per share (Unadj.) Rs279.00.3 87,307.3%  
Dividends per share (Unadj.) Rs167.000-  
Avg Dividend yield %2.50-  
Book value per share (Unadj.) Rs411.23.1 13,413.1%  
Shares outstanding (eoy) m23.03940.00 2.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.54.4 125.1%   
Avg P/E ratio x25.845.4 56.9%  
P/CF ratio (eoy) x24.238.3 63.3%  
Price / Book Value ratio x16.44.0 412.2%  
Dividend payout %63.80-   
Avg Mkt Cap Rs m155,65911,492 1,354.6%   
No. of employees `000NANA-   
Total wages/salary Rs m3,706336 1,104.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m28,5112,634 1,082.5%  
Other income Rs m665135 491.6%   
Total revenues Rs m29,1762,769 1,053.6%   
Gross profit Rs m8,203299 2,746.2%  
Depreciation Rs m39647 838.6%   
Interest Rs m1747 36.0%   
Profit before tax Rs m8,455340 2,490.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,42686 2,808.2%   
Profit after tax Rs m6,029253 2,381.7%  
Gross profit margin %28.811.3 253.7%  
Effective tax rate %28.725.4 112.8%   
Net profit margin %21.19.6 220.0%  
BALANCE SHEET DATA
Current assets Rs m31,3142,748 1,139.6%   
Current liabilities Rs m25,3471,065 2,379.4%   
Net working cap to sales %20.963.9 32.8%  
Current ratio x1.22.6 47.9%  
Inventory Days Days159102 155.2%  
Debtors Days Days171,432 1.2%  
Net fixed assets Rs m15,7141,299 1,209.9%   
Share capital Rs m230940 24.5%   
"Free" reserves Rs m9,2391,941 475.9%   
Net worth Rs m9,4692,881 328.6%   
Long term debt Rs m00-   
Total assets Rs m47,0284,047 1,162.1%  
Interest coverage x498.48.2 6,083.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.7 93.1%   
Return on assets %12.97.4 173.2%  
Return on equity %63.78.8 724.7%  
Return on capital %89.513.4 666.6%  
Exports to sales %18.065.0 27.8%   
Imports to sales %25.22.7 927.3%   
Exports (fob) Rs m5,1431,711 300.5%   
Imports (cif) Rs m7,17772 10,037.3%   
Fx inflow Rs m5,1431,711 300.5%   
Fx outflow Rs m7,17777 9,350.7%   
Net fx Rs m-2,0341,635 -124.4%   
CASH FLOW
From Operations Rs m2,304-60 -3,867.1%  
From Investments Rs m375830 45.2%  
From Financial Activity Rs m-8,783-146 6,033.1%  
Net Cashflow Rs m-6,104625 -976.6%  

Share Holding

Indian Promoters % 0.0 50.6 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 28.4 0.1 28,400.0%  
FIIs % 5.8 0.1 5,780.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 49.4 80.1%  
Shareholders   66,211 469,242 14.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on Sanofi India vs SYNCOM FORMULATIONS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Sanofi India vs SYNCOM FORMULATIONS Share Price Performance

Period Sanofi India SYNCOM FORMULATIONS S&P BSE HEALTHCARE
1-Day -1.10% -2.04% 0.11%
1-Month -9.20% -1.15% -3.22%
1-Year -21.51% 97.99% 42.65%
3-Year CAGR -9.01% 27.70% 19.86%
5-Year CAGR -2.49% 96.10% 25.90%

* Compound Annual Growth Rate

Here are more details on the Sanofi India share price and the SYNCOM FORMULATIONS share price.

Moving on to shareholding structures...

The promoters of Sanofi India hold a 60.4% stake in the company. In case of SYNCOM FORMULATIONS the stake stands at 50.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Sanofi India and the shareholding pattern of SYNCOM FORMULATIONS.

Finally, a word on dividends...

In the most recent financial year, Sanofi India paid a dividend of Rs 167.0 per share. This amounted to a Dividend Payout ratio of 63.8%.

SYNCOM FORMULATIONS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Sanofi India, and the dividend history of SYNCOM FORMULATIONS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23% Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23%(Closing)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.